Molecular Oncology
Volume 1, Issue 4 , Pages 366-373, April 2008

Cancer research in the UK: A policy review of the junior academic clinical faculty

  • Richard Sullivan

      Affiliations

    • Corresponding Author InformationTel.: +44 772 039 8401.
    • Professor & Chairman, European Cancer Research Managers Forum.
    web address

Department of Social Policy, London School of Economics and Political Science, Houghton Street, London WC2A 2AE, UK

Received 13 October 2007; accepted 23 October 2007. published online 16 November 2007.

Abstract 

Despite huge sums spent on academic clinical raining worldwide there is surprisingly little research to inform policymakers. This study addresses the junior faculty in the UK's cancer research community through both current Fellows and senior clinicians and policymakers. Funding organisations under the National Cancer Research Institute umbrella currently support 176 junior faculty fellows (studying towards MD [2 year postgraduate research degree] or PhD) with the majority in medical oncology (49%). Craft specialities (surgery and pathology) had a very modest presence in the junior faculty. The cancer research specific junior faculty makes up a major component of all available junior faculty from National Cancer Research Institute (NCRI) partners (ca. 31%) and is supported both by direct funding to Fellows and via junior faculty positions on clinical programme grants. There was almost universal support for the value of the research experience despite only two thirds of the current cohort expressing a desire to continue to the next level (Clinician Scientist grade). Major issues identified were mentorship, supervision time, pay parity and fit with new UK Clinical Research Collaboration / Modernising Medical Careers (UKCRC/MMC) clinician training programme.

Keywords: Training, Policy, Faculty

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1574-7891(07)00078-6

doi:10.1016/j.molonc.2007.10.005

Molecular Oncology
Volume 1, Issue 4 , Pages 366-373, April 2008